bibliographic resource 355066 [br/355066]
https://w3id.org/oc/corpus/br/355066

is a
title
  • Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
publication date
  • 2011-01-01
contributor
format
identifier
part of